Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon
Bloomage Biotechnology Corp Ltd
688363Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under the Hybloom, miniHA, microHA, Hyacross, Hyacolor, and cationHA. The company also provides food-grade sodium hyaluronate for use in food/healthy food/dietary supplements under the HAPLEX name, as well as food-grade gamma aminobutyric acid under the Gabarelax name; hyaluronic acid for oral care under the Biomoist name; and animal care products under the HYAPET names. Bloomage BioTechnology Corporation Limited was founded in 2000 and is headquartered in Jinan, the People's Republic of China. Address: Tech Development Zone, Jinan, China, 250101
Analytics
WallStreetin tavoitehinta
408.35 CNYP/E-suhde
71.2418Osinkotuotto
–Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Avainluvut 688363
Osinkoanalytiikka 688363
Osinkojen kasvu 5 vuoden aikana
–Jatkuva kasvu
3 vuottaMaksusuhde 5 vuoden keskiarvo
32 %Osinkohistoria 688363
Osakkeen arvostus 688363
Talousasiat 688363
Tuloksia | 2019 | Dynamiikka |